The effects of ‘supra-physiological’ vitamin B12 administration on temporary threshold shift
- 1 January 2004
- journal article
- research article
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 43 (3) , 162-165
Abstract
The aim of this study was to evaluate, in 20 young volunteer subjects, the effects of supra-physiological vitamin B12 administration on noise-induced temporary threshold shift (TTS). All subjects had hearing thresholds within 15dBHL and type A tympanograms. The subjects were randomly assigned to two different groups. Experimental group subjects received cyanocobalamin, 1 mg daily for 7 days, and 5 mg on the eighth day. Control group subjects received a placebo injection daily for 8 days. The vitamin B12 concentration, hearing thresholds and TTS2 (10 min of exposure, narrowband noise centred at 3 kHz, bandwidth of 775 Hz, 112 dB SPL) were measured before and 8 days after treatment. At the end of treatment, the serum vitamin B12 concentration was significantly increased in the experimental group. After 8 days of treatment, the control group showed the same hearing thresholds and TTS2 degrees. Statistical analysis showed that TTS2 decreased significantly at 3 and 4 kHz when cobalamin was used to increase the serum concentration of vitamin B12 to >2350 pg/ml. In addition, a protective effect at 3 kHz in the experimental group was evident when compared with the placebo group. These results suggest that elevated plasma cyanocobalamin levels may reduce the risk of hearing dysfunction resulting from noise exposure in healthy, young subjects. El propósito de este estudio fue evaluar, en 20 sujetos voluntarios jóvenes, los efectos de la administración supra-fisiológica de vitamina B12 sobre el cambio temporal de los umbrales auditivos inducido por ruido (TTS). Todos los sujetos tenían umbrales auditivos alrededor de 15 dB HL y timpanogramas tipo “A”, y fueron distribuidos al azar en dos grupos diferentes. Los sujetos del grupo experimental recibieron 1 mg diario de cianocobalamina por 7 días, y 5 mg en el octavo día. Los sujetos del grupo control recibieron una inyección diaria de placebo por 8 días. La concentración de vitamina B12, el umbral auditivo y el TTS2 (10 minutos de exposición, ruido de banda estrecha centrado en 3 kHz, ancho de banda de 775 Hz, 112 dB SPL) se midieron antes del tratamiento y 8 días después del mismo. Al final del tratamiento, la concentración sérica de vitamina B12 estaba significativamente elevada en el grupo experimental. Luego de 8 días de tratamiento, el grupo control mostró los mismos umbrales auditivos y grados de TTS2. El análisis estadístico mostró que el TTS2 disminuyó significativamente en 3 y 4 kHz, cuando se utilizó la cianocobalamina para aumentar las concentraciones séricas de vitamina B12 hasta>2350pg/ml. Además, fue evidente un efecto protector en 3 kHz en el grupo experimental cuando se comparó con el grupo placebo. Estos resultados sugieren que los niveles plasmáticos elevados de cianocobalamina pueden reducir el riesgo de disfunción auditiva como resultado de la exposición al ruido, en sujetos jóvenes sanos.Keywords
This publication has 15 references indexed in Scilit:
- The role of folic acid and Vitamin B12 in genomic stability of human cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- Improved Vascular Endothelial Function After Oral B VitaminsCirculation, 2000
- Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological functionInternational Journal of Geriatric Psychiatry, 2000
- Age-Related Hearing Impairment and B Vitamin StatusActa Oto-Laryngologica, 2000
- Folate and vitamin B12Proceedings of the Nutrition Society, 1999
- Age-related hearing loss, vitamin B-12, and folate in elderly womenThe American Journal of Clinical Nutrition, 1999
- Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young womenThe American Journal of Clinical Nutrition, 1998
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly PopulationJAMA, 1993
- Function of vitamin B12 in the central nervous system as revealed by congenital defectsAmerican Journal of Hematology, 1990